Bachem is proud to announce the release of Thymosin β4, Goserelin, Histrelin, Desmopressin and Exendin-4 immunology products. Thymosin b4 has been implicated in tumor metastasis by activating migration and angiogenesis, and is a suitable marker for breast and pancreatic cancer. Goserelin is a potent LHRH agonist which has been used for adjuvant therapy of prostate and breast cancer. Histrelin has been used to treat uterine fibroids in women and prostate cancer in men. Desmopressin is vasopressin analog which exhibits the high antidiuretic effect and also improves human learning and memory process. It is used to treat central diabetes insipidus, nocturnal enuresis (bedwetting), mild hemophilia A and thrombocytopenia. Exendin-4 is used to treat type I diabetes mellitus.
Peninsula Laboratories Inc. A Member of the Bachem Group 305 Old County Road San Carlos, California 94070 Customer Service: 650-592-5392800-922-1516 Tech Support: Fax Number: 650-595-4071 Web Site: http://www.bachem.com/
View the latest short animated film from BINDER on their KBF series constant climate chambers... watch video
Recently, I investigated the possibility of a novel fusion protein in lung tumors... read more
Stay updated on the latest technologies and news with Biocompare's newsletters (See samples here)